Lataa...
Nampt/PBEF/visfatin serum levels: a new biomarker for retinal blood vessel occlusions
The main objective of the study was to quantify serum levels of nicotinamide phosphoribosyltransferase (Nampt/pre-B-Cell colony-enhancing factor 1/visfatin) in subjects with a history of retinal vascular occlusions (RVOs), disease conditions characterized by pronounced ischemia, and metabolic energy...
Tallennettuna:
Julkaisussa: | Clin Ophthalmol |
---|---|
Päätekijät: | , , , , , , , , , , , , , |
Aineistotyyppi: | Artigo |
Kieli: | Inglês |
Julkaistu: |
Dove Medical Press
2015
|
Aiheet: | |
Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4396426/ https://ncbi.nlm.nih.gov/pubmed/25897200 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S80784 |
Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|